NetworkNewsBreaks

TuesdayMay 05, 2020 12:51 pm

NetworkNewsBreaks – InvestorBrandNetwork Launches NetworkWire – Providing White-Glove Service Far Beyond Traditional Newswire Offerings

InvestorBrandNetwork (“IBN”), an innovative corporate communications agency and content distributor, today announced the launch of NetworkWire (“NW”) as part of its continued commitment to expand available options that deliver mass exposure with targeted distribution. A game-changer for companies that wish to expand the visibility of their announcements, NetworkWire combines traditional wire-grade press release dissemination with assistance from a helpful, experienced team, offering expert press release enhancement services, follow-up article syndication via a network of more than 5,000 downstream partners and multi-brand social media distribution. NetworkWire, through this unprecedented cocktail of services, effectively helps public and private companies maximize their corporate…

Continue Reading

TuesdayMay 05, 2020 12:45 pm

NetworkNewsBreaks – Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) to Announce Q1 2020 Financial Results, Host Conference Call

Xeris Pharmaceuticals (NASDAQ: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, recently announced that it will release its first quarter 2020 financial results before the opening of the U.S. financial markets on Thursday, May 7, 2020. Per the update, Xeris management will host a conference call at 8:30 a.m. ET on the same day to discuss the Company’s financial and operational results. Interested parties may participate by dialing (866) 951-8137 (domestic) or (270) 215-9500 (international) and referencing conference ID 4666547. The live webcast will be accessible on…

Continue Reading

TuesdayMay 05, 2020 12:34 pm

NetworkNewsBreaks – Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) Secures $80.5 Million in Underwritten Public Offering

Arcturus Therapeutics Holdings (NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines, has closed an underwritten public offering of 4,735,297 shares of its common stock, including 617,647 additional shares pursuant to the full exercise of the over-allotment granted to the underwriters. According to the update, Arcturus Therapeutics secured approximately $80.5 million in gross proceeds, with each of the shares sold at the public offering price of $17.00. The company intends to use the proceeds for working capital and general corporate purposes, which may include R&D and…

Continue Reading

TuesdayMay 05, 2020 12:06 pm

NetworkNewsBreaks – National Storm Recovery’s (NSRI) Equipment Assets Through Recent Acquisition Valued Over $20.5 Million

National Storm Recovery Inc. (OTC: NSRI), a leading provider of environmentally beneficial solutions to tree and storm waste disposal, today announced a $20,503,975 valuation of its February 10, 2020 Mulch Manufacturing acquisition equipment assets through a third-party certified appraisal. This valuation strictly includes the production equipment located within different locations, as detailed in the update. “I am pleased with the result on the acquisition’s third party appraisal and the value it brings to our company,” NSRI’s CEO and Director Anthony Tony Raynor stated in the news release. “This is only the beginning and I look forward on sharing many other…

Continue Reading

TuesdayMay 05, 2020 12:05 pm

NetworkNewsBreaks – Global Diversified Marketing Group, Inc. (GDMK) Secures New Distribution Partner

Global Diversified Marketing Group (OTC: GDMK), a food and snack manufacturer, importer and distributor, announced on April 23 that it has secured distribution with Grocery Outlet Holding (NASDAQ: GO) to strengthen the company’s brand and, through a strategic partnership with the emerging industry leader, bring its Premium Biscottelli product line into an untapped segment of the consumer market. Grocery Outlet, a supermarket chain with roughly 350 stores, is currently capitalizing on shoppers that are stockpiling groceries. According to CNN.com, Grocery Outlet recently reported that sales at stores that have been open for at least one year surged 5.1% higher during…

Continue Reading

TuesdayMay 05, 2020 11:31 am

NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Featured in Dougherty & Company LLC Research Report

Trxade Group Inc. (NASDAQ: MEDS) was featured in a recent equity research report published by Dougherty & Company LLC. The report reads, “We reiterate our Buy rating and $12 Price Target on MEDS following Q1 results that beat expectations. As the only estimate on the Street, we note that revenue, EBITDA and EPS were each ahead of our forecast. MEDS added 305 new pharmacy registrations which was in line with our forecast of 300. We were pleased also with the “same-store” growth of pharmacy prescription volume which was up 14% y/y and drove the upside to our model. Results were…

Continue Reading

TuesdayMay 05, 2020 11:28 am

NetworkNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Achieves Record-Breaking Sales in April

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, today announced that the company achieved record sales during the last week of April. The company reported a significant increase in sales for the month of April, with numbers climbing more than 800% higher than the average monthly totals seen in calendar Q1. NUGS recently doubled its production capacity, enabling the company to continue to take on growing distributor relationships and larger orders in the California cannabis market. “The close of April represents an important signal in terms of business context. We have seen a number of…

Continue Reading

TuesdayMay 05, 2020 11:09 am

NetworkNewsBreaks – SinglePoint, Inc.’s (SING) Hemp Vertical on Track to Double Sales in Q2 Alongside Launch of 1606 Countertop Display

SinglePoint (OTCQB: SING) announced today that it is starting its second quarter with strong numbers and the focus on continued growth. According to the update, SinglePoint’s Hemp vertical is on track to double sales in Q2 alongside the launch of 1606 Hemp six-pack counter top display. 1606 Hemp has seen a 133% increase in sales growth this quarter, as well as a 233% growth in sales up to this point of the month compared to the same timeframe in the previous month.  SinglePoint has placed a focus on self-generated in store placement by hiring professional sales representatives to acquire new…

Continue Reading

TuesdayMay 05, 2020 10:34 am

NetworkNewsBreaks – Cannabis Global, Inc. (MCTC) Enters Game-Changing Agreement for Expansion in the California Cannabis Edibles and Beverages Marketplace

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, today announced its entry into a definitive, five-year agreement (the "Agreement") for the production of cannabis edibles and beverages in conjunction with licensed California cannabis operator, Magnolia Extracts, LLC of Lynwood, California. Under the Agreement, Cannabis Global will provide access to its trade secrets and patent pending technologies for chemical-free cannabis and hemp infusions in the production of edibles and beverages containing tetrahydrocannabinol (“THC”). "This deal represents an enormous escalation in terms of our positioning in the California cannabis edibles and beverages marketplace,"…

Continue Reading

TuesdayMay 05, 2020 10:26 am

NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Expands Oncology Franchise via Exclusive Worldwide Patent and Technology License Agreement

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced that it has entered into a patent and technology license agreement with The University of Texas MD Anderson Cancer Center, granting Genprex an exclusive worldwide license to a portfolio of 16 patent applications and related technology (“Licensed IP”) for the treatment of cancer using Genprex’s lead drug candidate and TUSC2 gene therapy, known as “Oncoprex” or “GEN-001,” in combination with immunotherapies. The Licensed IP covers the use of Oncoprex in combination with one or more immunotherapies for the treatment of…

Continue Reading